Renal Allograft Function and Histology Following Switching From A Tacrolimus to Sirolimus (SRL)-Based Immunosuppression-

NCT01166724 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped Collaborator stopped study

Conditions

Kidney Transplant

Interventions

DRUG: Sirolimus
DRUG: Tacrolimus

Sponsor

The Cleveland Clinic

Collaborators

[object Object]